Brain Network and Cognition
The largest neuroimaging dataset on bipolar disorder.
Brain Network and Cognition
The Brain Network and Cognition study (HUM00208378) is researching how brain networks communicate and influence quick decision-making in people living with bipolar disorder. The study uses functional magnetic resonance imaging (fMRI), a non-invasive brain scan, and computer-based neurocognitive assessments to understand the psychological and neural processes involved during decision making.
Since the Brain and Cognition study began in 2022, it has become the largest neuroimaging dataset on bipolar disorder!
- Adults ages 18-55
- Diagnosis of bipolar I or II OR no current or previous mental health diagnosis
- Has ability to complete 1-2 in-person visits
- Ability to complete an MRI scan
- No current substance abuse
Participants will complete an initial eligibility screen and a diagnostic interview with a study team member by phone or Zoom. The study team will determine if individuals are eligible to participate in the study after the initial phone or Zoom call. If eligible, participants will then complete an in-depth fMRI safety screening, and an interview to assess for a range of mental health conditions.
Following the screening and interview, there will be 1-2 in-person study visits involving:
- Mood questionnaires and interviews
- functional magnetic resonance imaging (fMRI) scan(s)
- Neurocognitive computer tasks testing working memory, attention, perception
If you complete the study in one session, you will receive an hour-long break in between sessions for lunch and travel between locations. Please be prepared to dedicate a full day to the study.
The fMRI scan will take place at the Bonisteel Interdisciplinary Research Building (2360 Bonisteel Blvd, Ann Arbor). You will receive a parking pass (free) to place in your car.
The neurocognitive session will take place at the Rachel Upjohn Building (4250 Plymouth Rd, Ann Arbor). Parking is free.
If you are interested in learning more about the study or to see if you are eligible for participation, click here to complete the screening questionnaire or contact the study team directly at 877-864-3637 or [email protected].
